Changes of expression of glucose transporters in the fetal lamb brain after MCI-186 administration to the maternal circulation with 10-min persistent umbilical cord occlusion

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue 10, 2009, Pages 829-836

  Watanabe, Masao ^a,b   Masaoka, Naoki ^c   Nakajima, Yoshiyuki ^c   Nagaishi, Masaji ^a   Yamamoto, Tatsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^c Tokyo Women s Medical University   (Japan)

Author keywords

Glucose transporter; Hypoxia ischemia reperfusion; MCI 186

Indexed keywords

GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 5; NORPHENAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; BASAL GANGLION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN OXYGEN TENSION; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; FETUS; FETUS BLOOD; GLUCOSE METABOLISM; HIPPOCAMPUS; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; LAMB; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; UMBILICAL CORD BLOOD FLOW;

ANIMALS; ANTIPYRINE; ARTERIAL OCCLUSIVE DISEASES; BRAIN; DRUG EVALUATION, PRECLINICAL; FEMALE; FETUS; FREE RADICAL SCAVENGERS; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HYPOXIA-ISCHEMIA, BRAIN; INJECTIONS, INTRAVENOUS; MATERNAL-FETAL EXCHANGE; NEUROPROTECTIVE AGENTS; PLACENTAL CIRCULATION; PREGNANCY; REPERFUSION INJURY; SHEEP; TIME FACTORS; UMBILICAL CORD;

EID: 70350678927     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050902801702     Document Type: Article

References (30)

1. Clapp JF, Press NS, Wesley M, Mann LI. Brain damage after intermittent partial cord occlusion in the chronically instrumented fetal lambs. Am J Obstet Gynecol 1988;159: 504-509.
2. Mallard EC, Gunn AJ, Williams CE, Johnston BM, Gluckman PD. Transient umbilical cord occlusion causes hippocampal damage in the fetal sheep. Am J Obstet Gynecol 1992;167:1423-1430.
3. De Hann HH, Gunn AJ, Williams CE, Gluckman PD. Brief repeated umbilical cord occlusions cause sustained cytotoxic cerebral edema and focal infarcts in near-term fetal lambs. Pediatr Res 1997;41:96-104.
4. Masaoka N, Nakajima Y, Hayakawa Y, Ohgame S, Nagaishi M, Yamamoto T. Transplacental effects of allopurinol on suppression of oxygen free radical production in chronically instrumented fetal lamb brains during intermittent umbilical cord occlusion. J Matern Fetal Neonatal Med 2005;18:1-7.
5. Nakajima Y, Masaoka N, Hayakawa Y, Watanabe M, Nagaishi M, Sakata H, Yamamoto T. The production of hydroxyl radicals in the fetal lamb brain resulting from occlusion of the umbilical circulation and the transplacental effect of MCI-186 to inhibit hydroxyl radical production. Pediatr Res 2006;59:216-220.
6. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randamized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003;15:222-222
7. Wu TW, Zeng LH, Wu J, Fung KP. MCI-186: further histochemical and biochemical evidence of neuroprotection. Life Sci 2000;67:2387-2392.
8. Mizuno A, Umemura K, Nakashima M. Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusion. Gen Pharmacol 1998;30:575-578. (Pubitemid 28102837)
9. Yamamoto T, Yuki S, Watanabe T, Mitsuka M, Saito KI, Kogure K. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 1997;762:240-242.
10. Yasuoka N, Nakajima W, Ishida A, Takada G. Neuroprotection of edaravone on hypoxic-ischemic brain injury in neonatal rats. Brain Res Dev Brain Res 2004;151:129-139.
11. Watanabe K, Morinaka Y, Iseki K, Watanabe T, Yuki S, Nishi H. Structure-activity relationship of 3-methyl-1- phenyl-2-pyrazolin-5-one (edaravone). Redox Rep 2003;8: 151-155.
12. Tsujita K, Shimomura H, Kawano H, Hokamaki J, Fukuda M, Yamashita T. Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 2004;94:481-484.
13. Abe T, Unno M, Takeuchi H, Kakita T, Katayose Y, Rikiyama T. A new free radical scavenger, edaravone, ameliorates oxidative liver damage due to ischemia-reperfusion in vivo. J Gastrointest Surg 2004;8:604-615.
14. Takahashi G, Sakurai M, Abe K, Itoyama Y, Tabayashi K. MCI-186 reduces oxidative cellular damage and increases DNA repair function in the rabbit spinal cord after transient ischemia. Ann Thorac Surg 2004;78:602-607.
15. Masaoka N, Nakajima Y, Watanabe M, Hayakawa Y, Nagaishi M, Yamamoto T, Honma T, Oinuma T, Nemoto N. MCI-186 administered to the maternal circulation inhibits fetal brain injury resulting from total umbilical cord occlusion in the chronically instumented fetal lamb. J Matern Fetal Neonat Med 2006;19:625-631.
16. Raichle ME. The pathophysiology of brain ischemia. Ann Neurol 1983;11:499-509.
17. Vannucci RC, Yager JY, Vannucci SJ. Cerebral glucose and energy utilization during the evolution of hypoxic-ischemic brain damage in the immature rat. J Cereb Blood Flow Metab 1994;14:279-288.
18. Maler F, Vannucci SJ, Simpson IA. Glucose transeporter proteins in brain. FASEB J 1994;8:1003-1011.
19. Nakamura S, Arakawa S, Nishiike S. A long-lasting change in the excitability of fetal brain neurons following activation of Dam's hypothalamus in rats. Am J Physiol 1995;269:R236-R244.
20. Sakata H, Fujioka T, Chowdhury GM, Nakamura S. In vivo electrical activity of brainstem neurons in fetal rats during asphyxia. Brain Res 2000;871:271-280.
21. Nehlig A, de Vasconcelos AP, Boyet S. Quantitative autoradiographic measurement of local cerebral glucose utilization in freely moving rats during postnatal development. J Neurosciense 1988;14:279-288.
22. Blennow M, Ingvar M, Legercrantz H, Stone-Elander S, Eriksson L, Forssberg H, Ericson K, Flodmark O. Early [18F] FDG positron emmsion tomography in infants with hypoxicischemic encephalopathy shows hypermetabolism during the postasphyctic period. Acta Pediatr 1995;84:1289-1295.
23. Wertheimer E, Sasson S, Cerasi E, Ben-Neriah Y. The ubiquitous glucose transeporter GLUT1 belongs to the glucose-regulated family of stress-inducible proteins. Proc Natl Acad Sci USA 1991;88:2525-2529.
24. Murakami T, Nishiyama T, Shinohara T, Kan Y, Ishii M, Kanai K, Nakazuru F, Ebina Y. Identification of two enhancer elements in the gene encoding the type I glucose transporter from the mouse which are responsive to serum, growth factor and oncogenes. J Biol Chem 1992;267:9300-9306.
25. Vannucci SJ, Seaman LB, Vannucci RC. Effect of hypoxiaischemia in GLUT1 and GLUT3 glucose transporters in immature rat brain. J Cereb Blood FlowMetab 1996;16:77-81.
26. Vannucci SJ, Reinhart R, Maher F, Bondy CA, Lee WH, Vannucci RJ, Simpson IA. Alterations in GLUT1 and GLUT3 glucose transporter gen expression following unilateral hypoxia-ischemia in the immature rat brain. Develop Brain Res 1998;107:255-264.
27. Chao CR, Hohimer AR, Bissonnette JM. Cerebral carbohydorate metabolism during sever ischemia in fetal sheep. L Cereb Blood Flow Metab 1989;9:53-57.
28. Lubec B, Chippe-Gutierrez M, Hoeger H, Kitzmueller E, Lubec G. Glucose transporters, hexokinase, and phosphofructokinase in brain of rat with perinatal asphyxia. Pediatr Res 2000;47:84-88. (Pubitemid 30038896)
29. Saliba E, Marret S. Cerebral white matter damage in the preterm infant: pathology and risk factors. Semin Neonatol 2001;6:121-133.
30. Rezaie P, Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002;22:106-132.